Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Q 35

Known as: Q-35 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Comparative pharmacokinetics and tolerability were studied in healthy elderly volunteers for two new fluoroquinolones… Expand
1995
1995
The bactericidal effects of Q-35, sparfloxacin, tosufloxacin, and ofloxacin on 18 strains of methicillin-resistant Staphylococcus… Expand
1995
1995
Q-35, a new fluoroquinolone, was evaluated for its in vitro and in vivo antibacterial activities. In vitro antibacterial activity… Expand
1995
1995
To investigate emerging fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan, we compared the in vitro… Expand
1995
1995
A sensitive high performance liquid chromatographic method for the determination in biological fluids of 1-cyclopropyl-6-fluoro-1… Expand
1994
1994
Q-35, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3- methylaminopiperidine-1-yl)-4-oxyquinoline-3-carboxylic acid, has… Expand
Highly Cited
1993
Highly Cited
1993
A newly developed fluoroquinoline, Q-35 (8-OCH3), in which a methoxy group was substituted at the 8 position of the quinoline… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
1993
1993
New carboxyquinolone drugs, including the recently developed Q-35, were evaluated for their in vitro potency against five… Expand
  • figure 1
  • table 1
1993
1993
The in vitro potency and in vivo efficacy of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae were investigated by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1992
1992
The in vitro activity of Q-35, an 8-methoxy fluoroquinolone, was compared with those of ofloxacin, ciprofloxacin, tosufloxacin… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2